期刊文献+

PCOS患者控制性超排卵方案的选择及比较 被引量:2

下载PDF
导出
摘要 PCOS是一种异质性疾病,具有多种表型,对促排卵药物反应异常,目前超排卵方案和超排卵药物多种多样,选择合适的控制性超排卵方案是PCOS患者获得ART成功的关键。
作者 许浩丽 丘映
出处 《生殖与避孕》 CAS CSCD 北大核心 2007年第10期672-678,共7页 Reproduction and Contraception
  • 相关文献

参考文献32

  • 1刘英,王树玉,张军,马延敏,任国庆,余兰.两种促卵泡生长激素在辅助生殖治疗效果的比较[J].生殖医学杂志,2004,13(3):172-174. 被引量:3
  • 2Bayram N,van Wely M,Patrono C,et al.Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Syst Rev,2001,1(2):CD002121.
  • 3Wood C,Downing B,Trounson A,et al.Clinical implations of develoments in in vitro fertilisation.Br Med J (Clin Res Ed),1984,289(6 450):978-80.
  • 4Hsieh Y,Tsai H,Chang C,et al.Comparison of a single half-dose long-acting form of gonadotropin-releasing hormone analog(GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program.Fertil Steril,2000,73(4):817-20.
  • 5Franks S,Adamas J,Mason H,et al.Ovulatory disorders in women with polycystic ovary syndrome.Clin Obestet Gynecol,1985,12(3):605-32.
  • 6Biljan MM,Mahutte NG,Tulandi T,et al.Prospective randomized double blind trail of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive endovgans.Fertil Steril,1999,71 (4):633-8.
  • 7木元正和(张维嘉摘).克罗米酚的增量、长期用药法[J].国外医学:计划生育分册,2001,20(2):119-119.
  • 8Porter RN,Smith W,Craft IL,et al.Induction for in vitro fertilization using buserlin and gonadotropins.Lancet,1984,2(8 414):1 284-5.
  • 9Nugent D,Vandekerchhove P,Weber SM,et al.Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Sys Rev,2000,3(4):CD000410.
  • 10Bahceci M,Ulug U,Pockj BA,et al.Use ofa GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovarydisease:a randomized,prospective,pilot study.J Reprod Med,2005,50(2):84-90.

二级参考文献33

  • 1刘锦霞,冷雯.多囊卵巢综合征患者外周血生长激素水平测定[J].生殖医学杂志,1994,3(3):150-152. 被引量:3
  • 2Steer CV, Mills CL, Tan Sl, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme[J]. Hum Reprod, 1992, 7(1): 117-119.
  • 3Fulghesu AM, Apa R, Belosi C, et al. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment[J]. Horm Res, 2001, 55(5): 224-228.
  • 4Battaglia C, Salvatori M, Regnani G, et al. Allergic reaction to a highly purified urinary follicle stimulating hormone preparation in controlled ovarian hyperstimulation for in vitro fertilization[J]. Gynecol Endocrinol, 2000,14(3):158-161.
  • 5Lenton E, Soltan A, Hewitt J, et al. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)[J]. Hum Reprod, 2000, 15(5): 1021-1027.
  • 6Kably A, Castelazo E, Barroso G. Comparative analysis of multifollicular development with the application of recombinant FSH vs urinary FSH in the results of in vitro fertilization[J]. Gynecol Obstet Mex, 2001, 69(2): 304-309.
  • 7Hugues JN, Bstandig B, Bry-Gauillard H, et al. Comparison of the effectiveness of recombinant and urinary FSH preparations in the achievement of follicular selection in chronic anovulation[J]. Reprod Biomed Online,2001, 3(3): 195-198.
  • 8Robertson WR. Gonadotrophin isoform patterns in different pharmaceutical preparations[A]. In: Kahn JA (ed). Gonadotropin isoforms: facts and future. Serono fertility series. Vol 2. Copenhagen: Ciconia Foundation, 1997.53-60.
  • 9Yong PY, Brett S, Baird DT, et al. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment[J]
  • 10Lathi RB, Milki AA. Recombinant gonadotropins[J]. Curr Womens Health Rep, 2001 , 1(2):157-163.

共引文献137

同被引文献19

  • 1张烁,杨晓丽,阎梦民,邓洋.基因重组卵泡刺激素促排卵效果的观察[J].山西医药杂志,2005,34(12):1033-1034. 被引量:8
  • 2陈新娜,卢光秀,严敬明,陈子江,肖红梅,陈贵安.重组FSH-β注射液在辅助生殖中的应用[J].实用妇产科杂志,2006,22(5):287-289. 被引量:2
  • 3中华医学会(主编).临床诊疗指南-辅助生殖与精予库分册.北京:人民卫生出版社,2009:81.
  • 4全松,陈雷宁(主译).体外受精与辅助生殖.北京:人民卫生出版社,2009:156.
  • 5Christin-Maitre S, Hugues JN, Recombinant FSH Study Group. A comparative randomized multicentric study com paring the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod, 2003,18(8):1626-31.
  • 6Sibug RM, Datson N, Tijssen AMI, et al. Effects of urinary and recombinant gonadotrophins on gene expression profiles during the murine peri-implantation period. Hum Reprod, 2007, 22(1):75-82.
  • 7Yovel I, Yajon Y, Amit A, et al. High progesterone levels adversely effect embryo quality and pregnancy rates in vitro fertilization and oocyte donation programs. Fertil Steril, 1995, 64(1):128.
  • 8Teisser M, Chable H, Paulhac S, et al. Recombinant human follicle stimulating hormone versus human menopausal go- nadotrophin induction: effects in mature follicle endocrinology. Hum Reprod, 1999, 14(9):2236-41.
  • 9Marrs RP, Meldrum DR, Muasher S J, et al. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online, 2004, 8(2): 175-82.
  • 10关冰.多囊卵巢综合症临床特点分析及诊治进展[J].中国医药指南,2007,5(7):102-105. 被引量:24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部